Vapotherm, Inc

(NYSE:VAPO)

$1.25

Created with Raphaël 2.1.23180-100100
STRONG BUY

Latest On Vapotherm, Inc (VAPO):

About Vapotherm, Inc (VAPO):

Vapotherm, Inc., a medical technology company, focuses on the development and commercialization of proprietary high velocity therapy products used to treat patients of various ages suffering from respiratory distress in the United States and internationally. The company offers precision flow systems, such as Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic, and Precision Flow Heliox that deliver heated, humidified, and oxygenated air at a high velocity to patients through a small-bore nasal interface. It also provides companion products, including Vapotherm Transfer Unit, which allows patients to be transferred between care areas within the hospital or ambulate while on therapy; Q50 compressor, which provides compressed air necessary to run the precision flow systems; aer read more...osol aeroneb adaptor to facilitate delivery of ultrasonic aerosolized medication; aerosol disposable patient circuit that is designed to streamline the provision of intermittent and continuous aerosol nebulization by limiting condensate management; and tracheostomy adaptors. In addition, Vapotherm, Inc. offers ProSoft cannula to provide gentle contact with the skin; and disposable products comprising single-use disposables and nasal interfaces, as well as Oxygen Assist Modules, which helps clinicians maintain oxygen levels within a target range. The company sells its products to hospitals. Vapotherm, Inc. was founded in 1993 and is based in Exeter, New Hampshire.

See Advanced Chart

General

  • Name Vapotherm, Inc
  • Symbol VAPO
  • Type Common Stock
  • Exchange NYSE
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryMedical Devices
  • Full Time Employees 397
  • Last Split Factor1:50
  • Last Split Date2014-09-10
  • Fiscal Year EndDecember
  • IPO Date2018-11-14
  • Gic SectorHealth Care
  • Gic GroupHealth Care Equipment & Services
  • Gic IndustryHealth Care Equipment & Supplies
  • Gic SubIndustryHealth Care Equipment
  • Web URLhttp://www.vapotherm.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 5
  • Price/Book (Most Recent Quarter) 5.98
  • Enterprise Value Revenue 4.93
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$2.28
  • Next Year EPS Estimate -$2.17
  • Next Quarter EPS Estimate -$0.54
  • Profit Margin -41%
  • Operating Margin -34%
  • Return on Assets -16%
  • Return on Equity -61%
  • Revenue 125.73 million
  • Earnings Per Share -$4.38
  • Revenue Per Share $5.28
  • Gross Profit 63.05 million
  • Quarterly Earnings Growth 214.4%
View More

Highlights

  • Market Capitalization 650.07 million
  • EBITDA -40608000
  • Analyst Target Price $41
  • Book Value Per Share $4.43
View More

Share Statistics

  • Shares Outstanding 25.81 million
  • Shares Float 17.46 million
  • % Held by Insiders 1133%
  • % Held by Institutions 95.98%
  • Shares Short 2.83 million
  • Shares Short Prior Month 1.84 million
  • Short Ratio 6.38
  • Short % of Float 14%
  • Short % of Shares Outstanding 11%
View More

Technicals

  • Beta -1.6
  • 52 Week High $54.42
  • 52 Week Low $10.55
  • 50 Day Moving Average 29.1
  • 200 Day Moving Average 28.56
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Vapotherm, Inc (VAPO) Dividend Calendar:

Vapotherm, Inc (VAPO) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Vapotherm, Inc (VAPO) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Vapotherm, Inc (VAPO) Chart:

Vapotherm, Inc (VAPO) News:

Below you will find a list of latest news for Vapotherm, Inc (VAPO) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Vapotherm, Inc (VAPO) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Latest VAPO Trades:

Vapotherm, Inc (VAPO) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Vapotherm, Inc (VAPO) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Vapotherm, Inc (VAPO). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 1133%
Institutional Ownership: 9598%